In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Laboratories Inc.

www.abbott.com

Latest From Abbott Laboratories Inc.

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

Coronavirus COVID-19 Approvals

Wall Street Tries To Guess The Impact Of Pandemic On Medtech Revenues

As the pandemic unfolds with an uncertain outcome, US securities analysts that cover publicly traded medtech companies are developing mathematical models to estimate the impact of the COVID-19 pandemic on medtech companies.

Coronavirus COVID-19 Companies

UK Court Blocks Edwards’ TAVR Device For Patent Infringement

Edwards’ Pascal transcatheter valve repair devices has been blocked from most use after being found to infringe on Abbott’s patents by a British court.

United Kingdom Commercial

Abbott Receives Emergency Use Authorization For COVID-19 Test

Abbott has become the next major diagnostics company to receive an Emergency Use Authorization from the US FDA for a COVID-19 test.

Coronavirus COVID-19 Infectious Diseases
See All

Company Information

UsernamePublicRestriction

Register